Research progress in monomers of traditional Chinese herbal medicine targeting PI3K/Akt/mTOR signaling pathway to prevent and treat diabetic nephropathy
|更新时间:2023-09-19
|
Research progress in monomers of traditional Chinese herbal medicine targeting PI3K/Akt/mTOR signaling pathway to prevent and treat diabetic nephropathy
Shanghai Journal of Traditional Chinese MedicineVol. 57, Issue 10, Pages: 83-88(2023)
WANG Wanting,XU Ying,SHAO Minghai.Research progress in monomers of traditional Chinese herbal medicine targeting PI3K/Akt/mTOR signaling pathway to prevent and treat diabetic nephropathy[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(10):83-88.
WANG Wanting,XU Ying,SHAO Minghai.Research progress in monomers of traditional Chinese herbal medicine targeting PI3K/Akt/mTOR signaling pathway to prevent and treat diabetic nephropathy[J].Shanghai Journal of Traditional Chinese Medicine,2023,57(10):83-88. DOI: 10.16305/j.1007-1334.2023.2301019.
Research progress in monomers of traditional Chinese herbal medicine targeting PI3K/Akt/mTOR signaling pathway to prevent and treat diabetic nephropathy
This article reviewed the research progress in monomers of traditional Chinese herbal medicine targeting PI3K/Akt/mTOR signaling pathway to prevent and treat diabetic nephropathy (DN). Studies have shown that PI3K/Akt/mTOR signaling pathway can inhibit inflammatory reaction, oxidative stress, apoptosis and autophagy, and plays an important role in the development and progression of DN. Monomers of traditional Chinese herbal medicine (baicalin, dendrobine, curcumin, notoginsenoside R1, platycodin D and osthole) can effectively prevent and treat DN by regulating PI3K/Akt/mTOR signaling pathway.
关键词
糖尿病肾病中药作用机制研究进展
Keywords
diabetic nephropathytraditional Chinese herbal medicinemechanism of actionresearch progress
references
MARTINEZ-CASTELAO A, NAVARRO-GONZALEZ J F, GORRIZ J L, et al. The concept and the epidemiology of diabetic nephropathy have changed in recent years[J]. J Clin Med, 2015, 4(6): 1207-1216.
DONG Y, ZHAO Q, WANG Y. Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy[J]. Sci Rep, 2021, 11(1): 19496.
YANG Y Q, TAN H B, ZHANG X Y, et al. The Chinese medicine Fufang Zhenzhu Tiaozhi capsule protects against renal injury and inflammation in mice with diabetic kidney disease[J]. J Ethnopharmacol, 2022, 292: 115165.
GUO H, GERMAN P, BAI S, et al. The PI3K/AKT pathway and renal cell carcinoma[J]. J Genet Genomics, 2015, 42(7): 343-353.
MANNING B D, TOKER A. AKT/PKB signaling: navigating the network[J]. Cell, 2017, 169(3): 381-405.
DIBBLE C C, CANTLEY L C. Regulation of mTORC1 by PI3K signaling[J]. Trends Cell Biol, 2015, 25(9): 545-555.
GUI Y, DAI C. mTOR signaling in kidney diseases[J]. Kidney360, 2020, 1(11): 1319-1327.
ELSHERBINY N M, AL-GAYYAR M M. The role of IL-18 in type 1 diabetic nephropathy: the problem and future treatment[J]. Cytokine, 2016, 81: 15-22.
LIN Y C, CHANG Y H, YANG S Y, et al. Update of pathophysiology and management of diabetic kidney disease[J]. J Formos Med Assoc, 2018, 117(8): 662-675.
WARREN A M, KNUDSEN S T, COOPER M E. Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies[J]. Expert Opin Ther Targets, 2019, 23(7): 579-591.
HONG J N, LI W W, WANG L L, et al. Jiangtang decoction ameliorate diabetic nephropathy through the regulation of PI3K/Akt-mediated NF-κB pathways in KK-Ay mice[J]. Chin Med, 2017, 12: 13.
COUGHLAN M T, SHARMA K. Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease[J]. Kidney Int, 2016, 90(2): 272-279.
GUCLUA, YONGUCN, DODURGA Y, et al. The effects of grape seed on apoptosis-related gene expression and oxidative stress in streptozotocin-induced diabetic rats[J]. Ren Fail, 2015, 37(2): 192-197.
SHARMA D, BHATTACHARYA P, KALIA K, et al. Diabetic nephropathy: new insights into established therapeutic paradigms and novel molecular targets[J]. Diabetes Res Clin Pract, 2017, 128: 91-108.
WIGHT T N, POTTER-PERIGO S. The extracellular matrix: an active or passive player in fibrosis?[J]. Am J Physiol Gastrointest Liver Physiol, 2011, 301(6): G950-G955.
LU Q, WANG W W, ZHANG M Z, et al. ROS induces epithelial-mesenchymal transition via the TGF-β1/PI3K/Akt/mTOR pathway in diabetic nephropathy[J]. Exp Ther Med, 2019, 17(1): 835-846.
LIAO J, LIU B, CHEN K, et al. Galangin attenuates oxidative stress-mediated apoptosis in high glucose-induced renal tubular epithelial cells through modulating renin-angiotensin system and PI3K/AKT/mTOR pathway[J]. Toxicol Res (Camb), 2021, 10(3): 551-560.
KIM K C, LEE I K, KANG K A, et al. 7,8-Dihydroxyflavone suppresses oxidative stress-induced base modification in DNA via induction of the repair enzyme 8-oxoguanine DNA glycosylase-1[J]. Biomed Res Int, 2013, 2013: 863720.
MAEZAWA Y, TAKEMOTO M, YOKOTE K. Cell biology of diabetic nephropathy: roles of endothelial cells, tubulointerstitial cells and podocytes[J]. J Diabetes Investig, 2015, 6(1): 3-15.
GARDAI S J, HILDEMAN D A, FRANKEL S K, et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils[J]. J Biol Chem, 2004, 279(20): 21085-21095.
QI X J, WILDEY G M, HOWE P H. Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function[J]. J Biol Chem, 2006, 281(2): 813-823.
PARCELLIER A, TINTIGNAC L A, ZHURAVLEVA E, et al. PKB and the mitochondria: AKTing on apoptosis[J]. Cell Signal, 2008, 20(1): 21-30.
SU H C, MA C T, YU B C, et al. Glycogen synthase kinase-3β regulates anti-inflammatory property of fluoxetine[J]. Int Immunopharmacol, 2012, 14(2): 150-156.
BENDER A, OPEL D, NAUMANN I, et al. PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis[J]. Oncogene, 2011, 30(4): 494-503.
LIN T A, WU V C, WANG C Y. Autophagy in chronic kidney diseases[J]. Cells, 2019, 8(1): 61.
KOCH E A T, NAKHOUL R, NAKHOUL F, et al. Autophagy in diabetic nephropathy: a review[J]. Int Urol Nephrol, 2020, 52(9): 1705-1712.
HE L, LIVINGSTON M J, DONG Z. Autophagy in acute kidney injury and repair[J]. Nephron Clin Pract, 2014, 127(1-4): 56-60.
CALNAN D R, BRUNET A. The FoxO code[J]. Oncogene, 2008, 27(16): 2276-2288.
EIJKELENBOOM A, BURGERING B M. FOXOs: signalling integrators for homeostasis maintenance[J]. Nat Rev Mol Cell Biol, 2013, 14(2): 83-97.
JUNG C H, RO S H, CAO J, et al. mTOR regulation of autophagy[J]. FEBS Lett, 2010, 584(7): 1287-1295.
LAPLANTE M, SABATINI D M. mTOR signaling at a glance[J]. J Cell Sci, 2009, 122(Pt 20): 3589-3594.
LIU J, LIU S, PAN W, et al. Wogonoside attenuates the articular cartilage injury and the infiltration of Th1/Th2-type cytokines in papain-induced osteoarthritis in rat model via inhibiting the NF-κB and ERK1/2 activation[J]. Immunopharmacol Immunotoxicol, 2021, 43(3): 343-352.
SUN Q R, ZHANG X, FANG K. Phenotype of vascular smooth muscle cells (VSMCs) is regulated by miR-29b by targeting Sirtuin 1[J]. Med Sci Monit, 2018, 24: 6599-6607.
OU Y, ZHANG W, CHEN S, et al. Baicalin improves podocyte injury in rats with diabetic nephropathy by inhibiting PI3K/Akt/mTOR signaling pathway[J]. Open Med (Wars), 2021, 16(1): 1286-1298.
PARSAMANESH N, MOOSSAVI M, BAHRAMI A, et al. Therapeutic potential of curcumin in diabetic complications[J]. Pharmacol Res, 2018, 136: 181-193.
TU Q, LI Y, JIN J, et al. Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells[J]. Pharm Biol, 2019, 57(1): 778-786.
SU P, DU S, LI H, et al. Notoginsenoside R1 inhibits oxidized low-density lipoprotein induced inflammatory cytokines production in human endothelial EA.hy926 cells[J]. Eur J Pharmacol, 2016, 770: 9-15.
YU Y, SUN G, LUO Y, et al. Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress-related signaling pathways[J]. Sci Rep, 2016, 6: 21730.
HUANG G, ZOU B, LV J, et al. Notoginsenoside R1 attenuates glucose-induced podocyte injury via the inhibition of apoptosis and the activation of autophagy through the PI3K/Akt/mTOR signaling pathway[J]. Int J Mol Med, 2017, 39(3): 559-568.
KIM T W, SONG I B, LEE H K, et al. Platycodin D, a triterpenoid sapoinin from Platycodon grandiflorum, ameliorates cisplatin-induced nephrotoxicity in mice[J]. Food Chem Toxicol, 2012, 50(12): 4254-4259.
Research progress in anti⁃tumor clinical efficacy and mechanism of action of Sarcandrae Herba
Research progress in anti⁃tumor regulation of metabolic reprogramming by active components of traditional Chinese herbal medicines
Research progress on mechanism of action of traditional Chinese herbal medicines for treating metabolism associated fatty liver disease
Research progress of traditional Chinese medicine in improving hyperuricemia by regulating uric acid transporter
Experimental research progress of Dendrobium nobile Lindl. in the treatment of diabetes and its related diseases
Related Author
No data
Related Institution
Shanghai University of Traditional Chinese Medicine
Sichuan Institute for Translational Chinese Medicine
Department of Oncology I, Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Department of Hepatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine